Columbia Biosciences Revenue and Competitors

Frederick, MD USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Columbia Biosciences's estimated annual revenue is currently $2M per year.(i)
  • Columbia Biosciences's estimated revenue per employee is $155,000

Employee Data

  • Columbia Biosciences has 13 Employees.(i)
  • Columbia Biosciences grew their employee count by 0% last year.

Columbia Biosciences's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Financial OfficerReveal Email/Phone
3
DIRECTOR OF MANUFACTURINGReveal Email/Phone
4
Director, Research and DevelopmentReveal Email/Phone
5
Associate Research ScientistReveal Email/Phone
6
Algae growerReveal Email/Phone
7
Production Technician IReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.3M2-60%N/AN/A
#2
$2.9M38-31%$17.5MN/A
#3
$2.9M38-33%$10.5MN/A
#4
$19.8M1280%$69.4MN/A
#5
$9.6M62-15%N/AN/A
#6
$1.4M90%N/AN/A
#7
$2.5M160%N/AN/A
#8
$7.4M480%N/AN/A
#9
$0.2M1-83%N/AN/A
#10
$1.7M1122%N/AN/A
Add Company

What Is Columbia Biosciences?

Columbia Biosciences Corporation, founded in 2007, develops and manufactures fluorescent proteins, antibody conjugates and novel protein purification ligands. In addition, our comprehensive custom services include antibody labeling, protein purification and discovery services such as functional cell based assays for pre-clinical drug development in oncology and immunology. Our expertise lies in the ability to integrate microalgae cultures with the isolation and purification of algal fluorophores, and with the conjugation of these and other fluorophores to antibodies. Columbia Biosciences’ fluorophores are integrated into a large number of life science products and diagnostic tools and are distributed globally.

keywords:N/A

N/A

Total Funding

13

Number of Employees

$2M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.4M14-18%N/A
#2
$2.3M15-44%N/A
#3
$1.4M16N/AN/A
#4
$2.5M167%N/A
#5
$1.4M167%N/A